BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32942047)

  • 1. Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures.
    Kumar M; Singh A; Kumari S; Kumar P; Wasi M; Mondal AK; Rudramurthy SM; Chakrabarti A; Gaur NA; Gow NAR; Prasad R
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158815. PubMed ID: 32942047
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    O'Brien B; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
    Silva V; Alvarado D; Diaz MC
    Med Mycol; 2004 Jun; 42(3):283-5. PubMed ID: 15283244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.
    Pathirana RU; Friedman J; Norris HL; Salvatori O; McCall AD; Kay J; Edgerton M
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158282
    [No Abstract]   [Full Text] [Related]  

  • 5. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
    Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
    Samra Z; Yardeni M; Peled N; Bishara J
    Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan.
    Yang YL; Cheng HH; Ho YA; Hsiao CF; Lo HJ
    J Microbiol Immunol Infect; 2003 Sep; 36(3):187-91. PubMed ID: 14582563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
    Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
    J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
    Sojakova M; Liptajova D; Borovsky M; Subik J
    Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
    Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
    Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.
    Astvad KMT; Johansen HK; Røder BL; Rosenvinge FS; Knudsen JD; Lemming L; Schønheyder HC; Hare RK; Kristensen L; Nielsen L; Gertsen JB; Dzajic E; Pedersen M; Østergård C; Olesen B; Søndergaard TS; Arendrup MC
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29212705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.